IRS1 and laryngeal squamous cell carcinoma: Previous studies have shown that lncRNA XIST promotes the development of laryngeal squamous cell carcinoma (LSCC) through stimulating miR-144 to regulate the expression of IRS1; interference with its expression can inhibit the proliferation, migration, and invasion of LSCC cells [35,36].